958P Phase I/II study of 7MW3711, a novel B7-H3-targeting antibody-drug conjugate (ADC), in patients with advanced solid tumors
Xinmei Liang(Hubei Cancer Hospital), Penghao Wang(Murdoch University), Shun Zhang(Peking University), Hengjun Chao(Hunan Cancer Hospital), Lili Yang(First Affiliated Hospital of Xinxiang Medical University), Yanru Qin(First Affiliated Hospital of Zhengzhou University), Shan Gao(Zhongda Hospital Southeast University), R. Stephanie Huang(Sun Yat-sen University), Cuihua Lu(Nantong University), Jinyu Zhang(Southwest Forestry University), Rui Liu(Hebei Medical University), Haowen Jiang(Beijing Friendship Hospital), Zhenfeng Zhang(Dalian Medical University), Rui Ding(Affiliated Hospital of Southwest Medical University), Yunchao Huang(North China University of Water Resources and Electric Power), Hui Guo(First Affiliated Hospital of Xi'an Jiaotong University), Shun Jiang(Central South University of Forestry and Technology), Qiang Peng(Affiliated Hospital of Southwest Medical University), Jie Chen(Guangdong Medical College), Tian Dai(Hunan Cancer Hospital)
Cited by 0
Related Papers
oncoPredict: an R package for predicting <i>in vivo</i> or cancer patient drug response and biomarkers from cell line screening data
|Briefings in Bioinformatics|2021|1.8k
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
|The Lancet Oncology|2015|1.6k
Highly siderophile element composition of the Earth’s primitive upper mantle: Constraints from new data on peridotite massifs and xenoliths
|Geochimica et Cosmochimica Acta|2006|599